Epilepsy

Viewing Page 1 of 1 | Showing Results 1 - 3 of 3

A Randomized, Double-blind, Placebo-controlled, Multicenter Study to Evaluate the Safety, Tolerability and Efficacy of XEN1101 as Adjunctive Therapy in Focal-onset Epilepsy

The XEN1101 Phase 2 clinical trial is a randomized, double-blind, placebo-controlled study that will evaluate the clinical efficacy, safety and...

Evan Fertig, M.D.
  • Providence Portland Medical Center
  • Providence St. Vincent Medical Center

RNS System Post-Approval Study in Epilepsy

The purpose of the study is to follow patients with partial onset seizures prospectively over 5 years in the real-world environment to gather data...

Ryder Gwinn, M.D.
  • Swedish Medical Center

A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Efficacy and Safety of Padsevonil as Adjunctive Treatment of Focal-Onset Seizures in Adult Subjects with Drug-Resistant Epilepsy

Key Inclusion Criteria:-Diagnosis of focal epilepsy per 1989 International League Against Epilepsy (ILAE) criteria at least 3 years before study...

Evan Fertig, M.D.
  • Providence Portland Medical Center
  • Providence St. Vincent Medical Center
Viewing Page 1 of 1 | Showing Results 1 - 3 of 3